Tags
You are here: Home
CMO
Pharma’s Future with a Disaggregated Supply Chain
New Rules -The game has changed for the global pharmaceutical industry. Numerous forces are shaping this new pharmaceutical era: The rise of emerging markets, increasing price pressure and expiring patents are just some of the factors forcing pharmaceutical companies to change the way they operate and how they manage their value chain.more
Pharma Must Make Big Changes to Survive
Patent cliff, the rise of "pharmerging" markets: These are just a few of the challenges the global pharmaceutical industry is facing. In order to ward off billions of dollars in losses, pharma companies will have to redesign their supply chains and become less squeamish about outsourcing more and more elements of their businesses.more
NNE Pharmaplan Extends International Business with A New Structure
Leading The Way - With sales of around €200 million in 2010, NNE Pharmaplan is one of the world's leading engineering and consulting companies for the pharmaceutical and biotechnology industries. Last year the group, whose headquarters are in Copenhagen, changed its organizational structure in order to improve its service to international customers and more consistently exploit opportunities for growth.The subsidiaries in Germany, Switzerland and France are part of the Central Europe Region. The German headquarters is in Bad Homburg, near Frankfurt. Dr. more
Flow Chemistry for Hazardous Reactions
Magic Pill? - The kick to expand flow chemistry into new application areas is a hot topic in chemistry and pharma. Driven by the vision of highly efficient processing, reputable players put enormous efforts into converting existing and new processes from batch to flow. Indisputably, the flow process has a potential but is it the pill to cure all headaches?Chemistry Between Flow and Batch
Continuous processes are work horses in the production of commodities such as petro and industrial bulk chemicals. more06.10.2010
Responding To Change
New Start - Major changes are impacting the pharmaceutical industry: the financial crisis, hard hitting government finances and health care budgets throughout the world, as well as patent cliff effects exacerbated by inadequate R&D productivity levels. Traditional business models applied by the pharmaceutical industry are being undermined, forcing change within the sector that also could spell out sweeping implications from the pharma CMO sector. more
The Other Side of the Coin
What do you consider to be the biggest trends in custom manufacturing? more
A Reliable Partner
The name of the game is focusing on core competencies - and this is something custom manufacturers have been able to benefit from over the last several years. This trend has set the scene for the industry's CMOs to show off their services. CMOs offer such services as API contract manufacturing; custom purification and separation; exclusive synthesis; and much more. Brandi Schuster asked some of this year's CPhI exhibitors the following questions:more
- Legal
- Help
- Participate
- Related Publications